GoodRx Holdings, Inc. (GDRX) vs MannKind Corporation (MNKD)
A side-by-side comparison of GoodRx Holdings, Inc. and MannKind Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GDRX
GoodRx Holdings, Inc.
$3.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MNKD
MannKind Corporation
$3.71HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — GDRX vs MNKD
growth of $100 · dividends reinvested · last 6yGDRX -93.3% (-36.3%/yr)MNKD +104.3% (+12.6%/yr)MNKD compounded faster over this window
Log scale — wide-divergence pair
GDRX MNKD
GDRX vs MNKD: by the numbers
- •MNKD is the larger company ($1.18B vs $1.13B market cap).
- •GDRX is profitable (2.07% net margin) while MNKD runs a net loss (-11.08%).
- •MNKD grew revenue faster over the past five years (39.51% vs 4.47% CAGR).
Metrics side by side
Valuation
| Metric | GDRX | MNKD |
|---|---|---|
| P/E ratio | 76.94 | N/A |
| P/S ratio | 1.44 | 3.01 |
| P/B ratio | 1.75 | N/A |
| EV / EBITDA | 8.14 | 51.23 |
| FCF yield | 12.86% | N/A |
Profitability
| Metric | GDRX | MNKD |
|---|---|---|
| Gross margin | 88.05% | 75.69% |
| Operating margin | 10.25% | 11.12% |
| Net margin | 2.07% | -11.08% |
| ROE | 2.51% | N/A |
| ROIC | 3.72% | 1.32% |
Growth (annualized)
| Metric | GDRX | MNKD |
|---|---|---|
| Revenue CAGR (5Y) | 4.47% | 39.51% |
| FCF CAGR (5Y) | 11.72% | N/A |
| Total return CAGR (5Y) | -39.98% | -4.18% |
Frequently asked
- Which has grown faster, GDRX or MNKD?
- Over the past five years, MNKD grew revenue faster — GDRX at a 4.47% CAGR versus MNKD at 39.51%.
- Is GDRX or MNKD more profitable?
- GDRX runs the higher net margin — GDRX at 2.07% versus MNKD at -11.08%.
- How have GDRX and MNKD total returns compared?
- Over the past 5 years, GDRX delivered -39.98% and MNKD delivered -4.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
GoodRx P/E ratioGoodRx ROEMannKind ROEGoodRx operating marginMannKind operating marginGoodRx revenue growthMannKind revenue growthGoodRx free cash flowMannKind free cash flow
GoodRx & MannKind appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.